Sift Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
Sift Bio General Information
Description
Developer of next-generation immunomodulators designed to treat cancer and autoimmune diseases. The company uses a combination of machine learning and high-throughput antigen screening to identify and develop therapeutic agents that modulate T-cell responses, enabling researchers to have more precise and effective treatments for a wide range of inflammatory and oncological conditions.
Contact Information
Website
www.siftbio.comCorporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Corporate Office
- 733 Industrial Road
- San Carlos, CA 94070
- United States
Sift Bio Timeline
Sift Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Accelerator/Incubator | 01-Jan-2026 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 18-Feb-2026 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 19-Sep-2025 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 13-Jun-2025 | Completed | Startup | |||
| 3. Accelerator/Incubator | 24-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 10-Sep-2024 | $1M | Completed | Pre-Clinical Trials | ||
| 1. University Spin-Out | 16-May-2024 | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sift Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sift Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sift Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eisai Innovation | Corporate Venture Capital | Minority | ||
| Freeflow Ventures | Venture Capital | Minority | ||
| LifeSpan Vision Ventures | Venture Capital | Minority | ||
| SBI Holdings | Holding Company | Minority | ||
| Valuence Ventures | Venture Capital | Minority |
Sift Bio FAQs
-
When was Sift Bio founded?
Sift Bio was founded in 2024.
-
Where is Sift Bio headquartered?
Sift Bio is headquartered in San Carlos, CA.
-
What is the size of Sift Bio?
Sift Bio has 9 total employees.
-
What industry is Sift Bio in?
Sift Bio’s primary industry is Drug Discovery.
-
Is Sift Bio a private or public company?
Sift Bio is a Private company.
-
What is Sift Bio’s current revenue?
The current revenue for Sift Bio is .
-
How much funding has Sift Bio raised over time?
Sift Bio has raised $7.4M.
-
Who are Sift Bio’s investors?
Eisai Innovation, Freeflow Ventures, LifeSpan Vision Ventures, SBI Holdings, and Valuence Ventures are 5 of 11 investors who have invested in Sift Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
